IR@PKUHSC  > 北京大学药学院
学科主题药学
Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis
Wu, Min1; Lu, Peng4; Shi, Luwen1; Li, Shao2,3
关键词traditional Chinese medicine cancer treatment medical insurance nationwide survey herb-drug network
刊名ONCOTARGET
2015-11-10
6期:35页:38283-38295
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Oncology ; Cell Biology
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
研究领域[WOS]Oncology ; Cell Biology
关键词[WOS]HERBAL FORMULAS ; ASTRAGALI-RADIX ; MATRINE ; CELLS
英文摘要

Based on the nationwide survey into inpatients′ utilization of the health service covered by China′s urban basic medical insurance from 2008 to 2010, we analyzed the use rate, cancer profile and combined use of anticancer Chinese patent medicines (CPMs) on 51,382 insured cancer patients by using statistical, bi-clustering and network methods. We found that 42.4% of 51,382 cancer patients used 33 anticancer CPMs, and 51.7% used 71 anticancer Western medicines (WMs). The CPMs were most often used in lung (52%) and nasopharynx (52%) cancer patients, and least in bladder cancer (21%) and leukemia of unspecified cell type (21%) patients. The cost per patient for all 33 anticancer CPMs was 2069RMB, lower than that of the WMs (3458RMB). The cancer profile of commonly used CPMs and WMs for the top 17 cancers (>500 sampled patients) were provided, indicating anticancer CPMs had a broad spectrum of cancers and lacked selectivity in cancer treatment (CPM mean CV = 49%; WM mean CV = 152%). Moreover, 24.8% of the cancer patients used both CPMs and WMs, and CPM-WM combined use networks were constructed for four major cancers. This first nationwide analysis revealed the use characteristics and herb-drug combined use patterns of insurance covered anticancer CPMs in China. The study offers valuable information to guide future studies of the precision, safety and standard use of CPMs.

语种英语
所属项目编号81225025 ; 91229201
资助者National Natural Science Foundation of China ; National Natural Science Foundation of China
WOS记录号WOS:000366113200096
Citation statistics
Cited Times:8[WOS]   [WOS Record]     [Related Records in WOS]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/62465
Collection北京大学药学院
作者单位1.Chinese Acad Sci, Inst Automat, Beijing, Peoples R China
2.Peking Univ, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China
3.Tsinghua Univ, Dept Automat, TNLIST, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China
4.Tsinghua Univ, Dept Automat, TNLIST, Bioinformat Div, Beijing 100084, Peoples R China
Recommended Citation
GB/T 7714
Wu, Min,Lu, Peng,Shi, Luwen,et al. Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis[J]. ONCOTARGET,2015,6(35):38283-38295.
APA Wu, Min,Lu, Peng,Shi, Luwen,&Li, Shao.(2015).Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis.ONCOTARGET,6(35),38283-38295.
MLA Wu, Min,et al."Traditional Chinese patent medicines for cancer treatment in China: a nationwide medical insurance data analysis".ONCOTARGET 6.35(2015):38283-38295.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
百度学术
百度学术Similar articles in
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
必应学术
必应学术Similar articles in
[Wu, Min]'s Articles
[Lu, Peng]'s Articles
[Shi, Luwen]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.